D
Diotheris
Shutdowndiotheris.com
Website unreachable since Oct 24, 2026
The startup develops bacterial therapies utilizing live bacteria to enhance the human skin and mucosal microbiome, specifically targeting pathogens like Staphylococcus aureus. Their products aim to prevent infections and protect patients from biological threats by restoring and maintaining a healthy microbial balance.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$710KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops bacterial therapies utilizing live bacteria to enhance the human skin and mucosal microbiome, specifically targeting pathogens like Staphylococcus aureus. Their products aim to prevent infections and protect patients from biological threats by restoring and maintaining a healthy microbial balance.